- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.04. | IO360 Summit: Improving CAR-T cell therapy manufacture and accessibility | ||
| 03.04. | AD/PD 2025: DHTs can detect disease progression in patients with early Parkinson's | ||
| 03.04. | ABPI calls on UK Government to resolve "VPAG crisis" | ||
| 03.04. | Atsena closes $150m in Series C round to progress gene therapy | ||
| 03.04. | IO360 summit: CAR-T cell therapy applications beyond blood cancer | ||
| 03.04. | Pharma industry dodges tariff blow but still braces for disruption | ||
| 03.04. | Weight loss implants to increase compliance and cut admin burden for patients | ||
| 03.04. | FDA grants accelerated approval to Novartis' Vanrafia for IgAN | ||
| 03.04. | The role of thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC) in modern pharmaceutical and herbal drug analysis | ||
| 03.04. | Astellas Pharma and JFCR partner for oncology research | ||
| 02.04. | UK life sciences venture capital funding lags behind | ||
| 02.04. | US uncertainty weighs on IPO market while UK innovation could benefit | ||
| 02.04. | ACC 2025: GLP-1RAs may reduce incidence of AF/flutter and stroke in diabetic patients | ||
| 02.04. | Organon acquires Actemra biosimilar's US rights from Biogen | ||
| 02.04. | RFK Jr swings axe at US health agencies | ||
| 02.04. | AIRNA secures $155m to bring RNA-candidate to clinic | ||
| 02.04. | Amneal and Shilpa introduce Boruzu in US for cancer treatment | ||
| 02.04. | FDA accepts priority review of Apellis' Empaveli sNDA for kidney diseases | ||
| 01.04. | Magazine: Are European biopharma manufacturers 'nearshoring'? | ||
| 01.04. | CNS market resurgence: a decade-long slump ends with $80bn milestone | ||
| 01.04. | Judge rejects J&J's $9bn talc settlement for third time | ||
| 01.04. | Reshoring efforts in US FMCG business begins, but cost increases are likely | ||
| 01.04. | Platform trials: The challenges, benefits, and best practices to maximize results with an EDC platform | ||
| 01.04. | BioVersys secures patent claims in China for BV100 | ||
| 01.04. | FDA approves Bavarian Nordic's freeze-dried mpox and smallpox vaccine |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
